Report Thumbnail
Product Code LP0914015486HW5
Published Date 2024/7/15
English111 PagesGlobal

Global Nephrostomy Guidewires Market Growth 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0914015486HW5◆The Jul 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/7/15
English 111 PagesGlobal

Global Nephrostomy Guidewires Market Growth 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

A nephrostomy guidewire is a medical device used in nephrostomy procedures to guide and position the nephrostomy catheter during surgery. A nephrostomy is a surgical procedure used to create a channel connecting the kidneys to the surface of the body for drainage of urine. During the operation, the doctor needs to guide and position the nephrostomy catheter through a guidewire to ensure that the operation proceeds smoothly. Nephrostomy guidewires are usually made of soft but strong material, such as plastic or wire. They are strong and flexible enough to travel within catheter channels and can be visualized and positioned using methods such as X-ray imaging. Guidewires usually have a sharp tip at one end to facilitate penetration of tissue during puncture and guidance.
The global Nephrostomy Guidewires market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Nephrostomy Guidewires Industry Forecast” looks at past sales and reviews total world Nephrostomy Guidewires sales in 2023, providing a comprehensive analysis by region and market sector of projected Nephrostomy Guidewires sales for 2024 through 2030. With Nephrostomy Guidewires sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nephrostomy Guidewires industry.
This Insight Report provides a comprehensive analysis of the global Nephrostomy Guidewires landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nephrostomy Guidewires portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nephrostomy Guidewires market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nephrostomy Guidewires and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nephrostomy Guidewires.
United States market for Nephrostomy Guidewires is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nephrostomy Guidewires is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nephrostomy Guidewires is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nephrostomy Guidewires players cover Boston Scientific, Teleflex, BD, B. Braun Melsungen, Coloplast, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nephrostomy Guidewires market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Metal Guide Wire
Plastic Guide Wire
Composite Guide Wire
Other
Segmentation by Application:
Kidney Stone Treatment
Congenital Kidney Malformation Treatment
Ureteral Obstruction Treatment
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Teleflex
BD
B. Braun Melsungen
Coloplast
Argon Medical Devices
UreSil
AngioDynamics
Envaste
Medi-Globe
Merit Medical
Marflow
Biometrix
BIOTRONIK
SURGIMEDIK
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nephrostomy Guidewires market?
What factors are driving Nephrostomy Guidewires market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nephrostomy Guidewires market opportunities vary by end market size?
How does Nephrostomy Guidewires break out by Type, by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Nephrostomy Guidewires Annual Sales 2019-2030
      • 2.1.2 World Current & Future Analysis for Nephrostomy Guidewires by Geographic Region, 2019, 2023 & 2030
      • 2.1.3 World Current & Future Analysis for Nephrostomy Guidewires by Country/Region, 2019, 2023 & 2030
    • 2.2 Nephrostomy Guidewires Segment by Type
      • 2.2.1 Metal Guide Wire
      • 2.2.2 Plastic Guide Wire
      • 2.2.3 Composite Guide Wire
      • 2.2.4 Other
    • 2.3 Nephrostomy Guidewires Sales by Type
      • 2.3.1 Global Nephrostomy Guidewires Sales Market Share by Type (2019-2024)
      • 2.3.2 Global Nephrostomy Guidewires Revenue and Market Share by Type (2019-2024)
      • 2.3.3 Global Nephrostomy Guidewires Sale Price by Type (2019-2024)
    • 2.4 Nephrostomy Guidewires Segment by Application
      • 2.4.1 Kidney Stone Treatment
      • 2.4.2 Congenital Kidney Malformation Treatment
      • 2.4.3 Ureteral Obstruction Treatment
      • 2.4.4 Other
    • 2.5 Nephrostomy Guidewires Sales by Application
      • 2.5.1 Global Nephrostomy Guidewires Sale Market Share by Application (2019-2024)
      • 2.5.2 Global Nephrostomy Guidewires Revenue and Market Share by Application (2019-2024)
      • 2.5.3 Global Nephrostomy Guidewires Sale Price by Application (2019-2024)
  • 3 Global by Company

    • 3.1 Global Nephrostomy Guidewires Breakdown Data by Company
      • 3.1.1 Global Nephrostomy Guidewires Annual Sales by Company (2019-2024)
      • 3.1.2 Global Nephrostomy Guidewires Sales Market Share by Company (2019-2024)
    • 3.2 Global Nephrostomy Guidewires Annual Revenue by Company (2019-2024)
      • 3.2.1 Global Nephrostomy Guidewires Revenue by Company (2019-2024)
      • 3.2.2 Global Nephrostomy Guidewires Revenue Market Share by Company (2019-2024)
    • 3.3 Global Nephrostomy Guidewires Sale Price by Company
    • 3.4 Key Manufacturers Nephrostomy Guidewires Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Nephrostomy Guidewires Product Location Distribution
      • 3.4.2 Players Nephrostomy Guidewires Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Nephrostomy Guidewires by Geographic Region

    • 4.1 World Historic Nephrostomy Guidewires Market Size by Geographic Region (2019-2024)
      • 4.1.1 Global Nephrostomy Guidewires Annual Sales by Geographic Region (2019-2024)
      • 4.1.2 Global Nephrostomy Guidewires Annual Revenue by Geographic Region (2019-2024)
    • 4.2 World Historic Nephrostomy Guidewires Market Size by Country/Region (2019-2024)
      • 4.2.1 Global Nephrostomy Guidewires Annual Sales by Country/Region (2019-2024)
      • 4.2.2 Global Nephrostomy Guidewires Annual Revenue by Country/Region (2019-2024)
    • 4.3 Americas Nephrostomy Guidewires Sales Growth
    • 4.4 APAC Nephrostomy Guidewires Sales Growth
    • 4.5 Europe Nephrostomy Guidewires Sales Growth
    • 4.6 Middle East & Africa Nephrostomy Guidewires Sales Growth
  • 5 Americas

    • 5.1 Americas Nephrostomy Guidewires Sales by Country
      • 5.1.1 Americas Nephrostomy Guidewires Sales by Country (2019-2024)
      • 5.1.2 Americas Nephrostomy Guidewires Revenue by Country (2019-2024)
    • 5.2 Americas Nephrostomy Guidewires Sales by Type (2019-2024)
    • 5.3 Americas Nephrostomy Guidewires Sales by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Nephrostomy Guidewires Sales by Region
      • 6.1.1 APAC Nephrostomy Guidewires Sales by Region (2019-2024)
      • 6.1.2 APAC Nephrostomy Guidewires Revenue by Region (2019-2024)
    • 6.2 APAC Nephrostomy Guidewires Sales by Type (2019-2024)
    • 6.3 APAC Nephrostomy Guidewires Sales by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Nephrostomy Guidewires by Country
      • 7.1.1 Europe Nephrostomy Guidewires Sales by Country (2019-2024)
      • 7.1.2 Europe Nephrostomy Guidewires Revenue by Country (2019-2024)
    • 7.2 Europe Nephrostomy Guidewires Sales by Type (2019-2024)
    • 7.3 Europe Nephrostomy Guidewires Sales by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Nephrostomy Guidewires by Country
      • 8.1.1 Middle East & Africa Nephrostomy Guidewires Sales by Country (2019-2024)
      • 8.1.2 Middle East & Africa Nephrostomy Guidewires Revenue by Country (2019-2024)
    • 8.2 Middle East & Africa Nephrostomy Guidewires Sales by Type (2019-2024)
    • 8.3 Middle East & Africa Nephrostomy Guidewires Sales by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Nephrostomy Guidewires
    • 10.3 Manufacturing Process Analysis of Nephrostomy Guidewires
    • 10.4 Industry Chain Structure of Nephrostomy Guidewires
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Nephrostomy Guidewires Distributors
    • 11.3 Nephrostomy Guidewires Customer
  • 12 World Forecast Review for Nephrostomy Guidewires by Geographic Region

    • 12.1 Global Nephrostomy Guidewires Market Size Forecast by Region
      • 12.1.1 Global Nephrostomy Guidewires Forecast by Region (2025-2030)
      • 12.1.2 Global Nephrostomy Guidewires Annual Revenue Forecast by Region (2025-2030)
    • 12.2 Americas Forecast by Country (2025-2030)
    • 12.3 APAC Forecast by Region (2025-2030)
    • 12.4 Europe Forecast by Country (2025-2030)
    • 12.5 Middle East & Africa Forecast by Country (2025-2030)
    • 12.6 Global Nephrostomy Guidewires Forecast by Type (2025-2030)
    • 12.7 Global Nephrostomy Guidewires Forecast by Application (2025-2030)
  • 13 Key Players Analysis

    • 13.1 Boston Scientific
      • 13.1.1 Boston Scientific Company Information
      • 13.1.2 Boston Scientific Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.1.3 Boston Scientific Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.1.4 Boston Scientific Main Business Overview
      • 13.1.5 Boston Scientific Latest Developments
    • 13.2 Teleflex
      • 13.2.1 Teleflex Company Information
      • 13.2.2 Teleflex Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.2.3 Teleflex Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.2.4 Teleflex Main Business Overview
      • 13.2.5 Teleflex Latest Developments
    • 13.3 BD
      • 13.3.1 BD Company Information
      • 13.3.2 BD Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.3.3 BD Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.3.4 BD Main Business Overview
      • 13.3.5 BD Latest Developments
    • 13.4 B. Braun Melsungen
      • 13.4.1 B. Braun Melsungen Company Information
      • 13.4.2 B. Braun Melsungen Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.4.3 B. Braun Melsungen Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.4.4 B. Braun Melsungen Main Business Overview
      • 13.4.5 B. Braun Melsungen Latest Developments
    • 13.5 Coloplast
      • 13.5.1 Coloplast Company Information
      • 13.5.2 Coloplast Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.5.3 Coloplast Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.5.4 Coloplast Main Business Overview
      • 13.5.5 Coloplast Latest Developments
    • 13.6 Argon Medical Devices
      • 13.6.1 Argon Medical Devices Company Information
      • 13.6.2 Argon Medical Devices Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.6.3 Argon Medical Devices Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.6.4 Argon Medical Devices Main Business Overview
      • 13.6.5 Argon Medical Devices Latest Developments
    • 13.7 UreSil
      • 13.7.1 UreSil Company Information
      • 13.7.2 UreSil Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.7.3 UreSil Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.7.4 UreSil Main Business Overview
      • 13.7.5 UreSil Latest Developments
    • 13.8 AngioDynamics
      • 13.8.1 AngioDynamics Company Information
      • 13.8.2 AngioDynamics Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.8.3 AngioDynamics Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.8.4 AngioDynamics Main Business Overview
      • 13.8.5 AngioDynamics Latest Developments
    • 13.9 Envaste
      • 13.9.1 Envaste Company Information
      • 13.9.2 Envaste Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.9.3 Envaste Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.9.4 Envaste Main Business Overview
      • 13.9.5 Envaste Latest Developments
    • 13.10 Medi-Globe
      • 13.10.1 Medi-Globe Company Information
      • 13.10.2 Medi-Globe Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.10.3 Medi-Globe Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.10.4 Medi-Globe Main Business Overview
      • 13.10.5 Medi-Globe Latest Developments
    • 13.11 Merit Medical
      • 13.11.1 Merit Medical Company Information
      • 13.11.2 Merit Medical Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.11.3 Merit Medical Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.11.4 Merit Medical Main Business Overview
      • 13.11.5 Merit Medical Latest Developments
    • 13.12 Marflow
      • 13.12.1 Marflow Company Information
      • 13.12.2 Marflow Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.12.3 Marflow Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.12.4 Marflow Main Business Overview
      • 13.12.5 Marflow Latest Developments
    • 13.13 Biometrix
      • 13.13.1 Biometrix Company Information
      • 13.13.2 Biometrix Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.13.3 Biometrix Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.13.4 Biometrix Main Business Overview
      • 13.13.5 Biometrix Latest Developments
    • 13.14 BIOTRONIK
      • 13.14.1 BIOTRONIK Company Information
      • 13.14.2 BIOTRONIK Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.14.3 BIOTRONIK Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.14.4 BIOTRONIK Main Business Overview
      • 13.14.5 BIOTRONIK Latest Developments
    • 13.15 SURGIMEDIK
      • 13.15.1 SURGIMEDIK Company Information
      • 13.15.2 SURGIMEDIK Nephrostomy Guidewires Product Portfolios and Specifications
      • 13.15.3 SURGIMEDIK Nephrostomy Guidewires Sales, Revenue, Price and Gross Margin (2019-2024)
      • 13.15.4 SURGIMEDIK Main Business Overview
      • 13.15.5 SURGIMEDIK Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.